Inventor
HAZAMA SHOICHI
JP11 patents
⚠️ This page may combine multiple inventors who share the name “HAZAMA SHOICHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CYTLIMIC INC
5 patentsUS11304997B2Apr 19, 2022
HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
CYTLIMIC INC0 citations60
US10875900B2Dec 29, 2020
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
CYTLIMIC INC0 citations50
US10590179B2Mar 17, 2020
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
CYTLIMIC INC0 citations50
US10537626B2Jan 21, 2020
HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
CYTLIMIC INC0 citations50
US10526388B2Jan 7, 2020
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells
CYTLIMIC INC0 citations50
NEC CORP
2 patentsUS12448413B2Oct 21, 2025
HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
NEC CORP0 citations61
US11618770B2Apr 4, 2023
MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same
NEC CORP0 citations61